Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge

<p>Abstract</p> <p>Aim</p> <p>This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem.</p> <p>Methods</p> <p>Twenty-four cases of...

Full description

Bibliographic Details
Main Authors: Roy Somak, Smith Matthew A, Cieply Kathy M, Acquafondata Marie B, Parwani Anil V
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Diagnostic Pathology
Subjects:
Online Access:http://www.diagnosticpathology.org/content/7/1/151
_version_ 1818526520607506432
author Roy Somak
Smith Matthew A
Cieply Kathy M
Acquafondata Marie B
Parwani Anil V
author_facet Roy Somak
Smith Matthew A
Cieply Kathy M
Acquafondata Marie B
Parwani Anil V
author_sort Roy Somak
collection DOAJ
description <p>Abstract</p> <p>Aim</p> <p>This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem.</p> <p>Methods</p> <p>Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the study with urothelial carcinoma (UC) and colonic adenocarcinoma (CA) as controls. A panel of immunohistochemical (IHC) stains along with fluorescence in-situ hybridization (FISH), using the UroVysion probe set, was performed.</p> <p>Results</p> <p>The majority of the PBAs presented with advanced disease. Enteric histologic subtype was the most common morphological variant. Strong nuclear with cytoplasmic-membranous staining of β-catenin was seen in 75% of MCA and only 16.7% PBA (<10% staining cells). Although abnormal nuclear staining with E-cadherin was seen in both PBA and MCA, it was more frequent in former. CK-7, CK-20, villin and CDX-2 stains were not helpful in distinguishing the two entities. FISH did not reveal any unique differences in chromosomal abnormality between the two groups.</p> <p>Conclusion</p> <p>Although there was a statistically significant difference in β-catenin and E-cadherin staining between two groups, we did not find any IHC or FISH marker that was specific for PBA. Distinction between PBA and MCA remains a diagnostic problem and clinical correlation is vital before rendering a diagnosis.</p> <p>Virtual slides</p> <p>The virtual slides for this article can be found here: <url>http://www.diagnosticpathology.diagnomx.eu/vs/1393156268152357</url></p>
first_indexed 2024-12-11T06:24:07Z
format Article
id doaj.art-97f0ffcb355e4874ac802a5ac3f54efa
institution Directory Open Access Journal
issn 1746-1596
language English
last_indexed 2024-12-11T06:24:07Z
publishDate 2012-11-01
publisher BMC
record_format Article
series Diagnostic Pathology
spelling doaj.art-97f0ffcb355e4874ac802a5ac3f54efa2022-12-22T01:17:44ZengBMCDiagnostic Pathology1746-15962012-11-017115110.1186/1746-1596-7-151Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challengeRoy SomakSmith Matthew ACieply Kathy MAcquafondata Marie BParwani Anil V<p>Abstract</p> <p>Aim</p> <p>This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem.</p> <p>Methods</p> <p>Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the study with urothelial carcinoma (UC) and colonic adenocarcinoma (CA) as controls. A panel of immunohistochemical (IHC) stains along with fluorescence in-situ hybridization (FISH), using the UroVysion probe set, was performed.</p> <p>Results</p> <p>The majority of the PBAs presented with advanced disease. Enteric histologic subtype was the most common morphological variant. Strong nuclear with cytoplasmic-membranous staining of β-catenin was seen in 75% of MCA and only 16.7% PBA (<10% staining cells). Although abnormal nuclear staining with E-cadherin was seen in both PBA and MCA, it was more frequent in former. CK-7, CK-20, villin and CDX-2 stains were not helpful in distinguishing the two entities. FISH did not reveal any unique differences in chromosomal abnormality between the two groups.</p> <p>Conclusion</p> <p>Although there was a statistically significant difference in β-catenin and E-cadherin staining between two groups, we did not find any IHC or FISH marker that was specific for PBA. Distinction between PBA and MCA remains a diagnostic problem and clinical correlation is vital before rendering a diagnosis.</p> <p>Virtual slides</p> <p>The virtual slides for this article can be found here: <url>http://www.diagnosticpathology.diagnomx.eu/vs/1393156268152357</url></p>http://www.diagnosticpathology.org/content/7/1/151BladderAdenocarcinomaPrimaryMetastaticColorectalBeta-cateninE-cadherin
spellingShingle Roy Somak
Smith Matthew A
Cieply Kathy M
Acquafondata Marie B
Parwani Anil V
Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
Diagnostic Pathology
Bladder
Adenocarcinoma
Primary
Metastatic
Colorectal
Beta-catenin
E-cadherin
title Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_full Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_fullStr Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_full_unstemmed Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_short Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_sort primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma a persisting diagnostic challenge
topic Bladder
Adenocarcinoma
Primary
Metastatic
Colorectal
Beta-catenin
E-cadherin
url http://www.diagnosticpathology.org/content/7/1/151
work_keys_str_mv AT roysomak primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT smithmatthewa primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT cieplykathym primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT acquafondatamarieb primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT parwanianilv primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge